Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

95% upper bound limit as per FDA for fully replicate crossover BE study [RSABE / ABEL]

posted by dshah – India/United Kingdom, 2021-01-05 09:06 (812 d 07:50 ago) – Posting: # 22174
Views: 1,488

Hi Yogeshla!

❝ Suppose 95% UB result is 0.001, is it acceptable to FDA?

The 95% UB would not be acceptable for 0.001.

Regards,
dshah

Complete thread:

95% upper bound limit as per FDA for fully replicate crossover BE study yogeshla 2021-01-05 07:01 [RSABE / ABEL]
- 95% upper bound limit as per FDA for fully replicate crossover BE studydshah 2021-01-05 08:06
  - 0.001 > 0 Helmut 2021-01-05 11:01
    - 0.001 > 0 yogeshla 2021-01-05 12:33

Admin contact
22,557 posts in 4,724 threads, 1,607 registered users;
27 visitors (0 registered, 27 guests [including 8 identified bots]).
Forum time: 17:56 CEST (Europe/Vienna)

Science is wonderfully equipped to answer the question “How?”
but it gets terribly confused when you ask the question “Why?” Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz